Immune damage in Long Covid.

Immune damage in Long Covid.

Publication date: Jan 19, 2024

Links between the complement and coagulation systems could lead to Long Covid therapies.

Open Access PDF

Concepts Keywords
Covid Coagulation
Damage Complement
Immune Covid
Long Damage
Therapies Immune


Type Source Name
disease MESH Long Covid
disease MESH infections
disease MESH syndrome
disease MESH thrombosis
disease MESH COVID 19
disease MESH thromboinflammation
disease IDO acute infection
disease IDO blood
disease MESH inflammation
pathway REACTOME Complement cascade
disease IDO host
drug DRUGBANK Thiocolchicoside
drug DRUGBANK Von Willebrand Factor Human
drug DRUGBANK Thrombin
disease VO USA
drug DRUGBANK Cysteamine
disease IDO susceptibility
disease VO inefficient
drug DRUGBANK Trestolone
disease IDO cell
disease VO antibody titer
disease MESH EBV infections
disease MESH autoimmunity
drug DRUGBANK Naproxen
drug DRUGBANK Tolbutamide

Original Article

(Visited 1 times, 1 visits today)